An interoperability roadmap

The Office of the National Coordinator for Health IT (ONC) continues its focus on interoperability, recently announcing its effort to draft a “living document” to accompany its 10-year interoperability vision.

Interoperability “is not going to happen overnight,” said Erica Galvez, ONC’s interoperability portfolio manager, at the Aug. 6 Health IT Policy Committee meeting. “A roadmap provides a path forward that everyone can rally behind and perhaps more importantly, collectively update over time.”

A new, online interactive community is cornerstone to this endeavor, providing a “deep dive” into how all stakeholders can achieve three-, six- and 10-year interoperability milestones, she said. Under these timelines:

  • By 2017, providers and individuals can send, receive, find and use a basic set of essential health information;
  • By 2020, an expansion of sources and users of information while continuing to improve quality and lower costs. Also an increase in automation and ability to scale broadly;
  • By 2024, stakeholders will practice precision medicine; reduce time from evidence to practice; and create a virtuous learning cycle or learning health system.

The roadmap will revolve around nine operating principles: building upon existing health IT infrastructure; one size does not fit all; leverage the market; consider the current environment and support multiple levels of advancement; simplify; focus on value; empower individuals; maintain modularity; and protect privacy and security in all aspects of interoperability.

Interested parties must weigh in by Sept. 12. What do you think of this living document?

Beth Walsh

Clinical Innovation + Technology editor

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.